Campbell & Co. Investment Adviser »

Keros Therapeutics shares owned by Campbell & Co. Investment Adviser

Quarter-by-quarter ownership of Keros Therapeutics (KROS) shares owned by Campbell & Co. Investment Adviser from 13F filings

Historical chart of Campbell & Co. Investment Adviser investment in Keros Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Keros Therapeutics held by Campbell & Co. Investment Adviser consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Keros Therapeutics by Campbell & Co. Investment Adviser

Quarter filed Position value Share count Share price at filing
2025-12-31 $359k 18k 20.36
2023-06-30 $311k 7.7k 40.18

More positions owned by Campbell & Co. Investment Adviser

Itt Common Stock (ITT)
Cheniere Energy Common Stock (LNG)
United Rentals Common Stock (URI)
BHP Group Adr (BHP)
Cullen/Frost Bankers Common Stock (CFR)
Pool Corp Common Stock (POOL)
Ameris Bancorp Common Stock (ABCB)
Bank of America Corp Common Stock (BAC)
Aecom Common Stock (ACM)
Associated Banc-Corp Common Stock (ASB)
DTE Energy Common Stock (DTE)
Netflix Common Stock (NFLX)
Allstate Corp/The Common Stock (ALL)
Labcorp Holdings Common Stock (LH)
Southwest Airlines Common Stock (LUV)

View all positions for Campbell & Co. Investment Adviser

Top funds holding Keros Therapeutics

BlackRock
Vanguard Group
Arrowstreet Capital, Limited Partnership
D. E. Shaw & Co
State Street Corporation
Alkeon Capital Management
Madison Avenue Partners
OrbiMed Advisors
Qube Research & Technologies
Jacobs Levy Equity Management
Federated Investors
Geode Capital Management
Nantahala Capital Management
Renaissance Technologies
Goldman Sachs Group

View all funds holding Keros Therapeutics